Rebound Pharma Private Limited
About Rebound Pharma Private Limited
Data last updated:
Rebound Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U52100WB2014PTC202785. Its GSTIN is 19AAGCR9840N1ZJ (West Bengal).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹22.5 Lakh. It is led by directors Gaurav Agarwal and Sourav Agarwal.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2021, the company reported a revenue of ₹79.21 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net loss of ₹27,075 (net margin -0.3%) and EBITDA of -₹11,082 (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rebound Pharma Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address111 Ashoka Appartment Shop No B Dr. Meghnand Saha Sarani ( Southurn Aven, Ue), Kolkata, West Bengal, India – 700029
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rebound Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rebound Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rebound Pharma Private Limited, buy the company report.
Financials of Rebound Pharma Private Limited
FY 2021 filings availableRebound Pharma Private Limited reported revenue of ₹79.21 Lakh (down 4% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 4% fall in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11,082 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹27,075 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rebound Pharma Private Limited, buy the company report.
Board of directors of Rebound Pharma Private Limited
Rebound Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Agarwal | Director | 19 Oct 2016 | 10 Years 0 Months | Current |
| Sourav Agarwal | Additional Director | 10 Jan 2015 | 11 Years 9 Months | Current |
Peer comparison
Rebound Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sigmus Biotech Private Limited | ₹79.41 Lakh (FY 2025) | 60.0% | Naraingarh, Haryana, India | |||
| Alpra Biotech Private Limited | ₹79.36 Lakh (FY 2025) | 11.0% | Patna, Bihar, India | |||
| CK Tradelink Private Limited | ₹79.22 Lakh (FY 2025) | 89.0% | Mana Camp, Chhattisgarh, India | |||
| Rebound Pharma Private Limitedthis company | ₹79.21 Lakh (FY 2021) | -₹27,075 | -0.3% | -4.0% | Kolkata, West Bengal, India | |
| S M X Farma Limited | ₹79 Lakh (FY 2025) | -88.0% | Delhi, India | |||
| A S Pharmaceutical (India) Private Limited | ₹78.99 Lakh (FY 2024) | -18.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Rebound Pharma Private Limited, buy the company report.
Auditor
Rebound Pharma Private Limited is audited by M N MITRA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M N MITRA & CO | FY 2020 | 323814E |
Shareholding
The shareholding of Rebound Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Rebound Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Mar 2017 | 100106542 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Rebound Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rebound Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rebound Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCR9840N1ZJ | West Bengal | Active | 12 Jul 2017 |
To see the full GST registrations and return filing status of Rebound Pharma Private Limited, buy the company report.
Recent activity
Rebound Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Rakesh Kumar Lunia ceased to be Director on 15 Feb 2017.
Frequently asked questions
Rebound Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 July 2014 (12+ years old) and is registered under CIN U52100WB2014PTC202785.
Rebound Pharma has 2 current directors:
- Gaurav Agarwal - Director
- Sourav Agarwal - Additional Director
The latest financial statements of Rebound Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Rebound Pharma is 19AAGCR9840N1ZJ, registered in West Bengal.
The CIN (Corporate Identification Number) of Rebound Pharma is U52100WB2014PTC202785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rebound Pharma was incorporated on 31 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Rebound Pharma by revenue are Sigmus Biotech Private Limited, Alpra Biotech Private Limited, CK Tradelink Private Limited, S M X Farma Limited, A S Pharmaceutical (India) Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rakesh Kumar Lunia ceased to be Director on 15 Feb 2017. Gaurav Agarwal was appointed as Director on 19 Oct 2016. Sushil Kumar Agarwal ceased to be Director on 13 Jan 2015. Rebound Pharma has 4 board changes on record in total.
The registered office of Rebound Pharma is at 111 Ashoka Appartment Shop No B Dr. Meghnand Saha Sarani Southurn Aven, Ue, Kolkata, West Bengal, India – 700029.
Rebound Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Rebound Pharma has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.